Published in Biomed Pharmacother on January 01, 1993
Adenylate energy charge in Escherichia coli during growth and starvation. J Bacteriol (1971) 8.19
False increase in C-reactive protein attributable to heterophilic antibodies in two renal transplant patients treated with rabbit antilymphocyte globulin. Clin Chem (1998) 2.03
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65
C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A (1998) 1.57
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD. Aliment Pharmacol Ther (2012) 1.57
Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis (2000) 1.55
Adenosine triphosphate conservation in biosynthetic regulation. Escherichia coli phosphoribosylpyrophosphate synthase. J Biol Chem (1967) 1.54
Interaction between energy charge and product feedback in the regulation of biosynthetic enzymes. Aspartokinase, phosphoribosyladenosine triphosphate synthetase, and phosphoribosyl pyrophosphate synthetase. Biochemistry (1968) 1.53
The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. Hum Exp Toxicol (2012) 1.39
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol (1999) 1.38
Interaction between energy charge and metabolite modulation in the regulation of enzymes of amphibolic sequences. Phosphofructokinase and pyruvate dehydrogenase. Biochemistry (1968) 1.34
RPBS: a web resource for structural bioinformatics. Nucleic Acids Res (2005) 1.28
Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis (1992) 1.25
Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. J Clin Microbiol (1993) 1.24
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium. Biomed Pharmacother (1994) 1.23
Acquired immunodeficiency syndrome in France. Lancet (1983) 1.21
New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2. Bone Marrow Transplant (2007) 1.21
Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res (1986) 1.19
Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas. Oncogene (2000) 1.18
Waist circumference cut-off points for identification of abdominal obesity among the tunisian adult population. Diabetes Obes Metab (2007) 1.16
Altered free radical metabolism in acute mountain sickness: implications for dynamic cerebral autoregulation and blood-brain barrier function. J Physiol (2008) 1.11
32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes. Lancet (1997) 1.10
Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol (2000) 1.09
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol (2007) 1.07
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc Natl Acad Sci U S A (1990) 1.05
Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.03
MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit. J Immunol (2001) 1.01
Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts. Eur J Endocrinol (1995) 1.01
Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes Metab (2006) 1.00
Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation. Clin Exp Immunol (2008) 1.00
Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: comparison with clofibrate. Food Chem Toxicol (2010) 1.00
Computer modeling of substrate binding to lipases from Rhizomucor miehei, Humicola lanuginosa, and Candida rugosa. Protein Sci (1994) 0.98
Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol (2005) 0.97
Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol (1999) 0.97
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol (2000) 0.96
[Hydatid cyst of the pancreas]. J Chir (Paris) (2005) 0.95
[Etiologic factors in primary bronchial carcinoma in Tunisia]. Tunis Med (1993) 0.93
[Infections in Senegalese children and adolescents with sickle cell anemia: epidemiological aspects]. Dakar Med (2000) 0.92
Oxygen binding to sickle cell hemoglobin. J Mol Biol (1979) 0.91
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins. J Pept Res (1998) 0.91
The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65. Eur J Immunol (2001) 0.91
Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Immunol Lett (1998) 0.90
[Low level educated community health workers training: a strategy to improve children access to acute respiratory treatment in Senegal]. Arch Pediatr (2006) 0.90
[Functional inhibition by cyclosporin A of the lymphocyte receptor for the AIDS virus (HIV)]. C R Acad Sci III (1986) 0.89
Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.89
Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol (1995) 0.89
Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes. Eur J Immunol (1986) 0.89
Tat toxoid as a component of a preventive vaccine in seronegative subjects. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.89
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategy. J Acquir Immune Defic Syndr (1992) 0.87
[Scorpion sting and acute interstitial nephropathy: Apropos of 1 case]. Med Trop (Mars) (2000) 0.87
Impairment of circulating lactoferrin in HIV-1 infection. Cell Mol Biol (Noisy-le-grand) (1995) 0.87
[Necrosis of the glans penis]. Rev Med Interne (2010) 0.87
Long-term biosynthesis of complement component C3 and alpha-1 acid glycoprotein by adult rat hepatocytes in a co-culture system with an epithelial liver cell-type. Biochem J (1986) 0.87
An immunochemical procedure to evaluate the degree of desialylation of alpha 1-acid glycoprotein in rat serum. J Immunol Methods (1984) 0.86
Hydatid cyst of the rib: a new case and review of the literature. Case Rep Med (2010) 0.86
Ligand-linked phase equilibria of sickle cell hemoglobin. J Mol Biol (1980) 0.86
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc Natl Acad Sci U S A (1993) 0.86
A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites. Int Immunol (1998) 0.86
Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol (1995) 0.85
Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual. AIDS Res Hum Retroviruses (1994) 0.84
[Desmoid cervical tumour following the placing of an internal jugular catheter]. Presse Med (2004) 0.84
Specificity of monoclonal antibody anti-T-6 for Langerhans' cells in normal human skin. Br J Dermatol (1982) 0.84
Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results. Biomed Pharmacother (1996) 0.84
Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate. Biochim Biophys Acta (1992) 0.83
[Embolism of cholesterol crystals simulating polymyositis: a case report]. Ann Med Interne (Paris) (1987) 0.83
Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease. Pathol Biol (Paris) (2011) 0.83
[Benign granular cell anal tumor]. Presse Med (2003) 0.82
Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2. Virus Res (1999) 0.82
HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. Biomed Pharmacother (1999) 0.82
Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft. Eur J Immunol (1998) 0.82
[Level of cardiovascular risk factors in the urban and rural populations of Cap-Bon: Tunisia]. Rev Epidemiol Sante Publique (1996) 0.82
Hemolytic uremic syndrome and prostatic adenocarcinoma. Clin Nephrol (1987) 0.82
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. Biomed Pharmacother (1994) 0.82
Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope. Vaccine (1993) 0.81
[Incidence of surgical wound infections a prospective study in the Rabat Mohamed-V military hospital, Morocco]. Med Mal Infect (2005) 0.81
Discriminating between protective and enhancing HIV antibodies. AIDS Res Hum Retroviruses (1990) 0.81
Complication of intramuscular/subcutaneous immune therapy in severely immune-compromised individuals. J Acquir Immune Defic Syndr (1991) 0.81
Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization. Virology (2000) 0.81
Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? Cell Death Differ (1995) 0.81
[Primary non-Hodgkin's malignant lymphoma of the adrenal gland. Case report and review of the literature]. Prog Urol (1999) 0.81
An unusual case of mycosis fungoides presenting as sarcoidosis or granulomatous mycosis fungoides. Am J Clin Pathol (1993) 0.80
[High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia]. Pathol Biol (Paris) (2004) 0.80